RecruitingSickle Cell DiseaseMeasles VaccinationSickle Cell Anemia
Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
Eligible age
0.5–6 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)
Sponsor: Children's Hospital Medical Center, Cincinnati
You may qualify if…
- ✓ 1. Participants with confirmed Sickle Cell Disease.
- ✓ 2. Participants 6 months and 6 years of age and due for measles vaccination within 3 months per national guidelines.
- ✓ 3. Willing and able to provide informed consent
- ✓ 4. Ability to comply with study related evaluations and follow-up visits.
You may not qualify if…
- ✕ 1\. Known primary immunodeficiency syndrome, cancer, or acquired immunodeficiency syndrome (AIDS) that would preclude vaccination with live virus vaccines.
Where it's recruiting
Ohio
Cincinnati
Source: ClinicalTrials.gov · NCT07356050 · last updated 2026-01-21